PMID: 15218406Jun 26, 2004Paper

Pharmacological management of persistent pain in older patients

The Clinical Journal of Pain
Perry G Fine

Abstract

The purpose of this manuscript is to foster understanding of the unique attributes of aging as they relate to the treatment of persistent pain in order to improve care of older patients. : A thorough review of pertinent recent literature, including clinical guidelines, provided the materials from which this synthesis is drawn. Several unique attributes of aging are identified that should be taken into account in order to provide safe and effective pharmacotherapy for older patients with persistent pain. Adherence to contemporary clinical guidelines should serve to promote improved outcomes in older patients who suffer from ongoing and debilitating pain. Since outcomes studies are lacking, attention to principles of care as they apply to this particular population is advised. Since each patient's experience and response to drug therapy will be unique, individualized assessment that incorporates an analysis of the patient's physiological state (comorbidities and concurrent drug therapies), a determination of realistic goals, and monitoring of outcomes on a regular basis will provide the optimum balance between benefits and risks of analgesic pharmacotherapy.

References

Apr 1, 1996·Journal of Pain and Symptom Management·R K Portenoy
Dec 10, 1998·JAMA : the Journal of the American Medical Association·M RowbothamL Magnus-Miller
Jan 27, 1999·Journal of the American Geriatrics Society·R M LeipzigM E Tinetti
Feb 3, 1999·Annals of the New York Academy of Sciences·G Barja
Feb 9, 2000·European Journal of Clinical Pharmacology·T Tomson, S I Johannessen
May 8, 2000·Journal of the American Geriatrics Society·G W CramerG D Thompson
Aug 26, 2000·Journal of Diabetes and Its Complications·Y HaratiM Kamin
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Feb 24, 2001·Journal of the American Geriatrics Society·F M Gloth
May 23, 2001·Journal of Pain and Symptom Management·M NugentS H Ahmedzai
Jul 19, 2001·Clinics in Geriatric Medicine·P G Fine
Aug 9, 2001·Journal of Clinical Pharmacy and Therapeutics·R B Raffa
Aug 16, 2001·Brain & Development·S J Wallace
Oct 17, 2001·Annals of Internal Medicine·C H MacLean
Dec 26, 2001·Anesthesiology·G Alec RookeCarl Rosow
Dec 26, 2001·Anesthesiology·Frédéric AubrunBruno Riou
Jan 12, 2002·JAMA : the Journal of the American Medical Association·Gregory P GebaUNKNOWN Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group
Feb 13, 2002·Journal of Palliative Medicine·Eduardo Bruera, Catherine Sweeney
May 25, 2002·Journal of the American Geriatrics Society·David H Solomon
Jun 18, 2002·Journal of the American Geriatrics Society·UNKNOWN AGS Panel on Persistent Pain in Older Persons

❮ Previous
Next ❯

Citations

Aug 21, 2010·American Journal of Public Health·Cynthia I CampbellMichael Von Korff
Aug 31, 2007·Drugs & Aging·Sebastiano Mercadante, Edoardo Arcuri
Sep 12, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·UNKNOWN American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons
Jul 31, 2012·Journal of Pain and Symptom Management·Kate L LapaneMyoung S Kim
Jul 4, 2009·Journal of the American Geriatrics Society·UNKNOWN American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons
Nov 7, 2006·Journal of Pain and Symptom Management·Sebastiano MercadanteAlessandra Casuccio
Apr 5, 2018·Clinical Hemorheology and Microcirculation·Samir K Ballas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.